Please login to the form below

Not currently logged in
Email:
Password:

drug discovery

This page shows the latest drug discovery news and features for those working in and with pharma, biotech and healthcare.

Merck’s backing of NGM Bio yields NASH drug deal

Merck’s backing of NGM Bio yields NASH drug deal

Drug has potential in diabetes treatment as well. Merck &Co’s four-year R&D collaboration with NGM Biopharmaceuticals has borne its first fruit, a license deal for a drug with ... into its biologic drug discovery expertise.

Latest news

  • Horizon Discovery and C4X to harness CRISPR for new cancer drugs Horizon Discovery and C4X to harness CRISPR for new cancer drugs

    The two UK-based companies are among a new generation of firms looking to use new drug discovery capabilities based on computer modelling and genomic tools to accelerate drug discovery and ... C4X Discovery (C4XD), a spin-out from the University of

  • Roche's O’Day swaps big pharma for big biotech Roche's O’Day swaps big pharma for big biotech

    with Sangamo to use its zinc finger gene-editing platform for drug discovery, and a $1.2bn deal to acquire Nimbus Therapeutics and its non-alcoholic steatohepatitis (NASH) candidate selonsertib.

  • AZ and CRUK launch Cambridge genomics centre AZ and CRUK launch Cambridge genomics centre

    disease - and how this knowledge can result in faster, more accurate drug discovery. ... Knowing the functional genomic drivers of disease increases the probability of success in drug discovery and early development, giving scientists an edge when it

  • UK life sciences gets some Brexit relief with £1.3bn sector deal UK life sciences gets some Brexit relief with £1.3bn sector deal

    run studies enabling faster and more efficient drug research. ... £50m to expand its UK presence, including a new global headquarters, and Celgene has set aside £22m for a five-year drug discovery collaboration with Cancer Research UK.

  • AI specialist Exscientia buys Kinetic Discovery AI specialist Exscientia buys Kinetic Discovery

    Exscientia has bolstered its drug discovery platform by acquiring Kinetic Discovery in a deal that it says will improve its ability to generate clinical candidates quickly. ... Exscientia, a specialist in applying artificial intelligence to drug discovery

More from news
Approximately 9 fully matching, plus 356 partially matching documents found.

Latest Intelligence

  • Unlocking the potential of science and technology in the UK Unlocking the potential of science and technology in the UK

    But it operates in an increasingly competitive global market, where strong demand for drug discovery and healthcare innovation is driving a race to innovate.

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    Meanwhile the national medicines regulator the Chinese Food and Drug Administration has also been reformed and renamed as the National Medical Products Administration of China (NMPA). ... complete with its own novel drug discovery and development

  • Regeneron and Bluebird sign $100m cell therapies deal Regeneron and Bluebird sign $100m cell therapies deal

    The collaboration draws on Regeneron’s VelociSuite platform technologies for the discovery and characterisation of fully human antibodies, as well as T cell receptors (TCRs) directed against tumour-specific proteins and ... Regeneron's George

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    Operating mostly under the radar this service has yet to market itself widely but the potential to identify cost-effective and clinically successful drug regimes is enormous. ... The fact that innovation outside the core drug discovery business is

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    Part two of our list of thirty women leaders 11-20. Jackie Hunter is a hugely experienced drug discovery scientist who is now championing the use of AI to transform pharma ... In the meantime, she is challenging not just the accepted ways of conducting

More from intelligence
Approximately 0 fully matching, plus 54 partially matching documents found.

Latest appointments

  • New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics

    Mader brings a track record of drug discovery experience to the biotech, most recently working for Eli Lilly, where she contributed to the development of multiple clinical candidates. ... Meanwhile, Mahesh Padval also joins Relay as senior vice president

  • Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team

    He has had the opportunity to work across the full spectrum of the drug lifecycle, from discovery to patent expiry, and his operational and strategic experiences will be vital assets that

  • Pharma industry appointments Pharma industry appointments

    Meanwhile, Silence Therapeutics has also bolstered its leadership team with the addition of Richard Jenkins, who joins the group following 28 years’ experience in clinical development and drug discovery. ... Concept Life Sciences appoints John Vu as

  • Concept Life Sciences adds to its team Concept Life Sciences adds to its team

    Matilda Bingham and David Higton join its Alderley Park site. Integrated drug discovery, development and analytical services company Concept Life Sciences has appointed Matilda Bingham as site director of its Alderley ... She said: “I am looking

  • Redx poaches AstraZeneca senior executive Redx poaches AstraZeneca senior executive

    Lisa Anson joins the UK biotech as its CEO. Drug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson.

More from appointments
Approximately 0 fully matching, plus 72 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics